LICH BRAD A 4

What Happened
Brad A. Lich, Executive Vice President & Chief Commercial Officer of Eastman Chemical Company (EMN), received equity awards on February 24, 2026: 63,123 derivative awards (stock-option type) and 8,684 restricted stock units (RSUs). The filing records a $0.00 acquisition price for both entries (i.e., these were grants/awards, not open-market purchases). No sale occurred—this is a compensation grant rather than a buy or sell.

Key Details

• Transaction date: February 24, 2026; Filing date: February 26, 2026 (filed within the standard 2‑business‑day window).
• Reported price: $0.00 (grants/awards; no cash paid at grant).
• Awards granted: 63,123 derivative awards (options); 8,684 restricted stock units (RSUs).
• Shares owned after transaction: Not stated in this Form 4 filing.
• Footnotes from the filing:
  • F1: One‑third of the options become exercisable on Feb 24 of 2027, 2028 and 2029, respectively.
  • F2: Each RSU represents a contingent right to receive one share of common stock.
  • F3: The RSUs vest and will be paid out in unrestricted shares on the third anniversary (Feb 24, 2029), subject to continued employment.

Context
The 63,123 awards are derivative option grants with multi‑year vesting (1/3 per year over three years). The 8,684 RSUs are time‑based and will convert to shares only if Mr. Lich remains employed through the payout date (Feb 24, 2029). These types of grants are standard executive compensation and do not represent an open‑market purchase (which some investors view as a stronger direct signal of insider conviction).